Pancreatic duct adenocarcinoma marker and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIV
- Publication Date
- 2018-08-28
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of tumor diagnosis and molecular targeted therapy, and relates to a tumor marker related to pancreatic ductal adenocarcinoma and its application. Background technique
[0002] In recent years, the incidence of pancreatic ductal adenocarcinoma (Pancreatic Duct Adenocarcinoma) has been increasing year by year worldwide. Due to the high degree of malignancy and rapid progression of pancreatic cancer, its prognosis is extremely poor, and the overall 5-year survival rate is less than 5%. Although radical surgical resection can improve the prognosis and increase the long-term survival rate, due to the hidden onset, rapid progression, and easy recurrence and metastasis of pancreatic cancer, the radical surgical resection rate is only 15%, and the 5-year survival rate after surgery is insufficient. 20%. In addition, pancreatic cancer still lacks specific chemotherapy drugs and targeted therapy drugs, which are not highly se...